NICE in U-turn over Alexion's Strensiq
Working at Alexion Pharmaceuticals,Inc.: 121 Reviews | Indeed.com
AZ's rare disease Ultomiris snags 3rd FDA nod
Articles with Alexion
Skanska Announces 121 Seaport Fully Leased as Alexion Pharmaceuticals Moves Headquarters to the Office Development | www.usa.skanska.com
Activist investor blasts Alexion's $1.4B Portola buy in scathing open letter | Fierce Pharma
Alexion Pharma to pay $8.4 billion for Synageva BioPharma
Alexion, other drugmakers pay $123M to settle kickback claims - Boston Business Journal
Alexion Pharmaceuticals, Inc.
Formation of a blood clot - Xconomy
Alexion finally has a buyer – and it's AstraZeneca with $39bn on the table | Pharmaphorum
ALEXION PHARMACEUTICALS INC (ALXN) Cost of Goods Sold By Year And By Quarter
Alexion Pharma | Fierce Pharma
Lessons We Can Learn from Alexion's Departure » CBIA
Alexion Pharmaceuticals invests in New Haven - Yale Daily News
Alexion Pharma Q4 2018 earnings | AlphaStreet
Customer Perspective: Alexion Pharmaceuticals, Inc. - Everbridge
Alexion acquiring Achillion to expand reach into rare disease
Elliott Management Is Said Push for Changes at Alexion - The New York Times
Alexion Says FDA Grants Orphan Drug Designation To ALXN1210 | World Pharma Today
Alexion Pharma Shares Jump 30% on AstraZenecas $39 Billion Buyout Offer
Alexion Pharmaceuticals – The New Economy
